Bariatric Surgery Devices - Medical Devices Pipeline Assessment, 2017

2017-09-08
Price :
Published : Sep-2017
No. of Pages : 163
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 10
2 Introduction 11
2.1 Bariatric Surgery Devices Overview 11
3 Products under Development 12
3.1 Bariatric Surgery Devices - Pipeline Products by Stage of Development 12
3.2 Bariatric Surgery Devices - Pipeline Products by Segment 13
3.3 Bariatric Surgery Devices - Pipeline Products by Territory 14
3.4 Bariatric Surgery Devices - Pipeline Products by Regulatory Path 15
3.5 Bariatric Surgery Devices - Pipeline Products by Estimated Approval Date 16
3.6 Bariatric Surgery Devices - Ongoing Clinical Trials 17
4 Bariatric Surgery Devices - Pipeline Products under Development by Companies 18
4.1 Bariatric Surgery Devices Companies - Pipeline Products by Stage of Development 18
4.2 Bariatric Surgery Devices - Pipeline Products by Stage of Development 20
5 Bariatric Surgery Devices Companies and Product Overview 22
5.1 3DT Holdings, LLC Company Overview 22
5.1.1 3DT Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
5.2 Allurion Technologies, Inc. Company Overview 23
5.2.1 Allurion Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.3 Apollo Endosurgery Inc Company Overview 26
5.3.1 Apollo Endosurgery Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.4 Applied Medical Resources Corporation Company Overview 27
5.4.1 Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview 27
5.5 BAROnova, Inc. Company Overview 28
5.5.1 BAROnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
5.6 BFKW, LLC Company Overview 31
5.6.1 BFKW, LLC Pipeline Products & Ongoing Clinical Trials Overview 31
5.7 Boston Scientific Corp Company Overview 32
5.7.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 32
5.8 C. R. Bard Inc Company Overview 33
5.8.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.9 Columbia University Company Overview 34
5.9.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 34
5.10 Crospon Ltd Company Overview 35
5.10.1 Crospon Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
5.11 EndoRetics Inc. Company Overview 36
5.11.1 EndoRetics Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.12 EndoVx Inc Company Overview 37
5.12.1 EndoVx Inc Pipeline Products & Ongoing Clinical Trials Overview 37
5.13 EnteroMedics Inc Company Overview 38
5.13.1 EnteroMedics Inc Pipeline Products & Ongoing Clinical Trials Overview 38
5.14 Gelesis Inc Company Overview 41
5.14.1 Gelesis Inc Pipeline Products & Ongoing Clinical Trials Overview 41
5.15 GI Dynamics Inc Company Overview 47
5.15.1 GI Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 47
5.16 Hebrew University of Jerusalem Company Overview 51
5.16.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 51
5.17 Innovia LLC Company Overview 52
5.17.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 52
5.18 John Hopkins University Company Overview 54
5.18.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 54
5.19 Mayo Clinic US Company Overview 55
5.19.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 55
5.20 Medi-Globe GmbH Company Overview 56
5.20.1 Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview 56
5.21 MetaModix, Inc Company Overview 57
5.21.1 MetaModix, Inc Pipeline Products & Ongoing Clinical Trials Overview 57
5.22 Mmtc, Inc. Company Overview 59
5.22.1 Mmtc, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.23 National University of Singapore Company Overview 60
5.23.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 60
5.24 Precision Medical Devices, Inc. Company Overview 61
5.24.1 Precision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
5.25 Satiety Inc Company Overview 62
5.25.1 Satiety Inc Pipeline Products & Ongoing Clinical Trials Overview 62
5.26 Sensate LLC Company Overview 65
5.26.1 Sensate LLC Pipeline Products & Ongoing Clinical Trials Overview 65
5.27 Silhouette Medical, Inc. Company Overview 66
5.27.1 Silhouette Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.28 SLIMEDICS LTD Company Overview 67
5.28.1 SLIMEDICS LTD Pipeline Products & Ongoing Clinical Trials Overview 67
5.29 Spatz FGIA, Inc Company Overview 68
5.29.1 Spatz FGIA, Inc Pipeline Products & Ongoing Clinical Trials Overview 68
5.30 Standard Bariatrics, Inc. Company Overview 69
5.30.1 Standard Bariatrics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69
5.31 Surefire Medical Inc Company Overview 70
5.31.1 Surefire Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 70
5.32 SynerZ Medical, Inc. Company Overview 71
5.32.1 SynerZ Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
5.33 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview 72
5.33.1 The Sheikh Zayed Institute for Pediatric Surgical Innovation Pipeline Products & Ongoing Clinical Trials Overview 72
5.34 TransEnterix, Inc. Company Overview 73
5.34.1 TransEnterix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
5.35 Tulip Medical Ltd. Company Overview 74
5.35.1 Tulip Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 74
5.36 UAS LifeSciences LLC Company Overview 75
5.36.1 UAS LifeSciences LLC Pipeline Products & Ongoing Clinical Trials Overview 75
5.37 University of Florida Company Overview 76
5.37.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 76
5.38 University of Miami Company Overview 77
5.38.1 University of Miami Pipeline Products & Ongoing Clinical Trials Overview 77
5.39 ValenTx, Inc. Company Overview 78
5.39.1 ValenTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
5.40 Vancive Medical Technologies Company Overview 81
5.40.1 Vancive Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview 81
5.41 Vibrynt, Inc. Company Overview 82
5.41.1 Vibrynt, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
6 Bariatric Surgery Devices- Recent Developments 83
6.1 Aug 31, 2017: Apollo Endosurgery Announces 20-year LAP-BAND Outcomes Data Presented at 22nd IFSO World Congress in London 83
6.2 Aug 30, 2017: Apollo Endosurgery Announces CE Mark Approval for the ORBERA365 Managed Weight Loss System, Expanding the Indwell Period from 6 Months to 12 Months with the Gastric Balloon Category Leader 84
6.3 Aug 23, 2017: GI Dynamics Appoints Juliet Thompson to Company's Board of Directors 84
6.4 Aug 23, 2017: Senior Novartis Executive Joins Proteus Digital Health as Chief Financial Officer 85
6.5 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 86
6.6 Aug 21, 2017: EnteroMedics Announces First Veterans Choice Program vBloc Implant at MedStar Health in Maryland 88
6.7 Aug 16, 2017: EnteroMedics Announces Presentations Highlighting vBloc and Gastric Vest at IFSO Annual Conference 89
6.8 Aug 13, 2017: GI Dynamics Welcomes New Members to its Scientific Advisory Board 90
6.9 Aug 10, 2017: Apollo Endosurgery Provides Update And Clarity To FDA Letter To Health Care Providers Related To Potential Risks Of Intragastric Balloons 91
6.10 Aug 08, 2017: EnteroMedics Announces Second Quarter 2017 Financial Results 92
6.11 Aug 02, 2017: Obalon Announces Second Quarter 2017 Financial Results 93
6.12 Aug 01, 2017: Apollo Endosurgery Reports Second Quarter 2017 Results 93
6.13 Jul 31, 2017: EnteroMedics Receives Approval for Gastric Vest System Clinical Study in Spain 95
6.14 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 95
6.15 Jul 12, 2017: Gelesis Announces Last Patient Out in the Pivotal Gelesis100 Weight-Loss Study 97
6.16 Jul 12, 2017: Gelesis Announces Data on Gelesis200 98
6.17 Jul 12, 2017: Apollo Endosurgery Reports Preliminary Unaudited Financial Estimates for the Second Quarter of 2017 98
6.18 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 99
6.19 Jun 21, 2017: Aspire Bariatrics Announces AspireAssist Receives Australian TGA Approval and First Commercial Cases Performed in Australia 101
6.20 Jun 21, 2017: EnteroMedics Announces vBloc Therapy to be Presented by Keynote Speaker at Major International Obesity Conference 101
6.21 Jun 19, 2017: GI Dynamics Announces Additional Members to Its Scientific Advisory Board 102
6.22 Jun 11, 2017: First Data Derived from ABCD Worldwide EndoBarrier Registry Presented at ADA Shows Sustained Metabolic Improvements in Patients with Obesity and Type 2 Diabetes at Six Months Post-explant 103
6.23 Jun 02, 2017: GI Dynamics Announces Change to Board of Directors 104
6.24 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 104
6.25 May 19, 2017: Vizient Submits Comments to the FDA about Biosimilar Interchangeability, Looks Forward to Working toward Lowering Drug Costs 107
6.26 May 16, 2017: EnteroMedics Announces First Quarter 2017 Financial Results 107
6.27 May 11, 2017: Obalon Receives Regulatory Approvals to Commercialize in Select Middle East Markets 108
6.28 May 10, 2017: Obalon Announces First Quarter 2017 Financial Results 108
6.29 May 08, 2017: GI Dynamics Announces Scientific Advisory Board Members to Further Development of EndoBarrier 108
6.30 May 04, 2017: Apollo Endosurgery Reports First Quarter 2017 Results 109
6.31 May 03, 2017: GI Dynamics Announces EndoBarrier Data to be Presented at Digestive Disease Week 111
6.32 May 02, 2017: Apollo Endosurgery To Present Data on ORBERA Intragastric Balloon System at Digestive Disease Week 2017 Conference 112
6.33 Apr 28, 2017: Obalon Balloon System to be Included in Two Presentations at the Aesthetic Meeting 2017 112
6.34 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 113
6.35 Apr 25, 2017: BarioSurg Showcasing Its Next Generation Obesity Technology, the Gastric Vest System at the VII Medical Congress Angeles Group 114
6.36 Apr 23, 2017: Bard Announces First Quarter Results 114
6.37 Apr 03, 2017: Michigan Physician Successfully Performs First AspireAssist Non-Surgical Weight Loss Procedures In The State 115
6.38 Mar 28, 2017: Genesis Automation Awarded Group Purchasing Contract with Vizient To Provide Integrated Supply Chain Management Technology 116
6.39 Mar 15, 2017: David Moatazedi Joins Obalon Therapeutics Board of Directors 116
6.40 Mar 13, 2017: GI Dynamics Announces Scientific Advisory Board Members to Further Scientific Understanding of EndoBarrier 117
6.41 Mar 08, 2017: Apollo Endosurgery Reports Fourth Quarter and Full Year 2016 Results 117
6.42 Mar 07, 2017: GI Dynamics Announces New Scientific Advisory Board and Board's First Two Members 119
6.43 Mar 07, 2017: EnteroMedics Reports Fourth Quarter 2016 Financial Results 120
6.44 Mar 06, 2017: TransEnterix Reports Operating Results for the Fourth Quarter and Full Year 2016 121
6.45 Mar 01, 2017: ZELTIQ Announces Fourth Quarter and Full Year 2016 Financial Results 122
6.46 Feb 23, 2017: Obalon Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results 124
6.47 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 125
6.48 Feb 09, 2017: EnteroMedics Announces Publication of Three-Year Data from vBloc Diabetic Patient Study in Journal of Diabetes and Obesity 127
6.49 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 128
6.50 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 129
6.51 Jan 31, 2017: GI Dynamics: Quarterly Report - Quarter Ended 31 December 2016 130
6.52 Jan 30, 2017: New Jersey Bariatric Center Performs First Obalon Gastric Balloon Procedure for Weight Loss in NJ 130
6.53 Jan 26, 2017: Bard Announces Fourth Quarter Results 131
6.54 Jan 25, 2017: BAROnova Announces Completion of ENDObesity II Pivotal Clinical Trial Enrollment 132
6.55 Jan 24, 2017: Mayo Clinic Selects Vizient as Its Performance Improvement Partner 132
6.56 Jan 18, 2017: FDA Approves Obalon Balloon System 133
6.57 Jan 17, 2017: Apollo Endosurgery Appoints Dr. Christopher J. Gostout as Chief Medical Officer 133
6.58 Jan 17, 2017: Jonah Shacknai Joins Obalon Therapeutics Board of Directors 134
6.59 Jan 13, 2017: Obalon Announces Initial Commercial Patient Placements of the First and Only Swallowable, FDA-Approved Balloon System for Weight Loss 134
6.60 Jan 11, 2017: GI Dynamics Provides 2017 Business Outlook and 2016 Review 135
6.61 Jan 09, 2017: ZELTIQ Reports Preliminary Fourth Quarter and Full Year 2016 Revenue and Provides 2017 Guidance 136
6.62 Jan 09, 2017: ZELTIQ Aesthetics Announces Commercial Leadership Transition 138
6.63 Jan 05, 2017: Aspire Bariatrics Announces Two-Year Observational Study Results Published in BMC Obesity for AspireAssist 138
6.64 Jan 05, 2017: GI Dynamics Appoints Oern R. Stuge, MD, Amid Change to Company's Board of Directors 139
6.65 Dec 14, 2016: BMI of Texas Selected as Exclusive Provider of Obalon System 140
6.66 Dec 06, 2016: AspireAssist Pivotal Trial Results Published in the American Journal of Gastroenterology 140
6.67 Dec 06, 2016: Dedicated to Innovation: Next-Generation Vanquish ME Device from BTL Aesthetics Reduces 53% More Fat Than its Predecessor 141
6.68 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 142
6.69 Nov 22, 2016: EnteroMedics Provides Commercialization and Corporate Update 145
6.70 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 146
6.71 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 147
6.72 Nov 11, 2016: Obalon Therapeutics Announces Third Quarter Financial Results 147
6.73 Nov 09, 2016: TransEnterix Reports Operating Results for the Third Quarter 2016 148
6.74 Nov 09, 2016: ZELTIQ Announces Third Quarter 2016 Financial Results 149
6.75 Nov 04, 2016: ReShape Medical Unveils US Commercial Data Demonstrating Increased Weight Loss with ReShape Dual Balloon 150
6.76 Nov 04, 2016: Obalon Announces Data Presentation at the Annual Meeting of the American Society for Metabolic and Bariatric Surgery 151
6.77 Nov 02, 2016: Apollo Endosurgery Announces Successful Completion of LAP-BAND FDA Post-Approval Study 152
6.78 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 153
6.79 Oct 25, 2016: Bard Announces Third Quarter Results 154
6.80 Oct 17, 2016: Freudenberg Medical Recognized at Medical Device Design Excellence Awards 155
6.81 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 155
6.82 Sep 28, 2016: New York Bariatric Group is the First Medical Practice in America Since FDA Approval to Perform Non Surgical Weight Loss Solution - AspireAssist 156
6.83 Sep 28, 2016: Vizient Launches Ediom, a Cognitive Computing and Data Science Company 156
6.84 Sep 27, 2016: EnteroMedics Announces Appointment of Dan Gladney as Chairman of the Board of Directors 157
6.85 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 157
6.86 Sep 12, 2016: Obalon Announces FDA Approval Of Obalon Balloon System 158
7 Appendix 160
7.1 Methodology 160
7.2 About GlobalData 163
7.3 Contact Us 163
7.4 Disclaimer 163

1.1 List of Tables
Table 1: Bariatric Surgery Devices - Pipeline Products by Stage of Development 12
Table 2: Bariatric Surgery Devices - Pipeline Products by Segment 13
Table 3: Bariatric Surgery Devices - Pipeline Products by Territory 14
Table 4: Bariatric Surgery Devices - Pipeline Products by Regulatory Path 15
Table 5: Bariatric Surgery Devices - Pipeline Products by Estimated Approval Date 16
Table 6: Bariatric Surgery Devices - Ongoing Clinical Trials 17
Table 7: Bariatric Surgery Devices Companies - Pipeline Products by Stage of Development 18
Table 8: Bariatric Surgery Devices - Pipeline Products by Stage of Development 20
Table 9: 3DT Holdings, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
Table 10: Gastric Sleeve Magnetic Implant - Product Status 22
Table 11: Gastric Sleeve Magnetic Implant - Product Description 22
Table 12: Allurion Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 13: Elipse Balloon - Product Status 23
Table 14: Elipse Balloon - Product Description 23
Table 15: Allurion Technologies, Inc. - Ongoing Clinical Trials Overview 24
Table 16: Elipse Balloon - A Randomized, Multi-center, Phased, Pivotal Safety and Efficacy Study Comparing the Elipse Gastric Balloon System Versus Sham for the Treatment of Obese Adults 25
Table 17: Elipse Balloon - Pilot Trial of the Elipse Intragastric Balloon System for the Treatment of Overweight and Obese Individuals 25
Table 18: Apollo Endosurgery Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 19: ORBERA365 Managed Weight Loss System - Product Status 26
Table 20: ORBERA365 Managed Weight Loss System - Product Description 26
Table 21: Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview 27
Table 22: Next Generation Bariatric Surgical Device - Product Status 27
Table 23: Next Generation Bariatric Surgical Device - Product Description 27
Table 24: BAROnova, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
Table 25: TransPyloric Shuttle Device - Product Status 28
Table 26: TransPyloric Shuttle Device - Product Description 28
Table 27: BAROnova, Inc. - Ongoing Clinical Trials Overview 29
Table 28: TransPyloric Shuttle Device - Endoscopic Treatment for Weight Reduction in Patients with Obesity Using the TransPyloric Shuttle System: A Multicenter, Prospective, Randomized, Double-blind, Sham-controlled, Parallel-design Study 30
Table 29: BFKW, LLC Pipeline Products & Ongoing Clinical Trials Overview 31
Table 30: Full Sense - Product Status 31
Table 31: Full Sense - Product Description 31
Table 32: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 32
Table 33: TERIS - Product Status 32
Table 34: TERIS - Product Description 32
Table 35: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 36: Restore Suturing System - Product Status 33
Table 37: Restore Suturing System - Product Description 33
Table 38: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 34
Table 39: Gastric Bypass Shunt - Product Status 34
Table 40: Gastric Bypass Shunt - Product Description 34
Table 41: Crospon Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
Table 42: BaroFLIP System - Product Status 35
Table 43: BaroFLIP System - Product Description 35
Table 44: EndoRetics Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
Table 45: Endoretics Device - Product Status 36
Table 46: Endoretics Device - Product Description 36
Table 47: EndoVx Inc Pipeline Products & Ongoing Clinical Trials Overview 37
Table 48: EndoVx Device - Product Status 37
Table 49: EndoVx Device - Product Description 37
Table 50: EnteroMedics Inc Pipeline Products & Ongoing Clinical Trials Overview 38
Table 51: Gastric Vest System - Product Status 38
Table 52: Gastric Vest System - Product Description 38
Table 53: EnteroMedics Inc - Ongoing Clinical Trials Overview 39
Table 54: Gastric Vest System - Safety and Performance Study for the Gastric Vest System: CE Mark Study 40
Table 55: Gelesis Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 56: Gelesis100 - Product Status 41
Table 57: Gelesis100 - Product Description 41
Table 58: Gelesis100 Pediatric And Obese Overweight - Product Status 42
Table 59: Gelesis100 Pediatric And Obese Overweight - Product Description 42
Table 60: Gelesis100 Prediabetic And Diabetic Overweight - Product Status 42
Table 61: Gelesis100 Prediabetic And Diabetic Overweight - Product Description 43
Table 62: Gelesis200 - Product Status 43
Table 63: Gelesis200 - Product Description 43
Table 64: Gelesis Inc - Ongoing Clinical Trials Overview 44
Table 65: Gelesis100 - A Randomized, Double-blind, Placebo-controlled, Parallel-group Study Assessing the Effect of Gelesis100 on Body Weight in Overweight and Obese Subjects with and without Type 2 Diabetes 45
Table 66: Gelesis100 - An Open-label Study Assessing the Effect of Gelesis100 on Weight Loss and Weight Maintenance in Overweight and Obese Subjects Who Completed the GLOW Study (G-04) 45
Table 67: Gelesis200 - A Randomized, Double-blind, Placebo-controlled, Parallel-group Study Assessing the Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects with Prediabetes and Met Forming-treated Type 2 Diabetes 46
Table 68: Gelesis200 - A Randomized, Open-label, Crossover Study Assessing the Effects of Gelesis200 on Glucose and Insulin Following a Single Administration of Gelesis200 in Healthy Subjects 46
Table 69: GI Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 47
Table 70: EndoBarrier Flow Restrictor - Product Status 47
Table 71: EndoBarrier Flow Restrictor - Product Description 48
Table 72: EndoBarrier Liner With EndoBarrier Restrictor - Product Status 48
Table 73: EndoBarrier Liner With EndoBarrier Restrictor - Product Description 48
Table 74: GI Dynamics Inc - Ongoing Clinical Trials Overview 49
Table 75: EndoBarrier Liner With EndoBarrier Restrictor - Endoscopic Treatment of Obesity with a Duodenal-jejunal Bypass Sleeve: Does Impairment of Fat Absorption Explain Weight Loss 50
Table 76: EndoBarrier Liner With EndoBarrier Restrictor - Randomisation to Endoluminal Intestinal Liner Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity) 50
Table 77: Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 51
Table 78: MetaboShield - Product Status 51
Table 79: MetaboShield - Product Description 51
Table 80: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 52
Table 81: Gastric Balloon - Product Status 52
Table 82: Gastric Balloon - Product Description 52
Table 83: Gastric Sleeve - Product Status 53
Table 84: Gastric Sleeve - Product Description 53
Table 85: Laparoscopic Band - Product Status 53
Table 86: Laparoscopic Band - Product Description 53
Table 87: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 54
Table 88: Image-guided Bariatric Arterial Embolization Device - Product Status 54
Table 89: Image-guided Bariatric Arterial Embolization Device - Product Description 54
Table 90: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 55
Table 91: Endoscopic Therapy Device - Obesity - Product Status 55
Table 92: Endoscopic Therapy Device - Obesity - Product Description 55
Table 93: Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview 56
Table 94: Medi-Globe Gastric Balloon - Product Status 56
Table 95: Medi-Globe Gastric Balloon - Product Description 56
Table 96: MetaModix, Inc Pipeline Products & Ongoing Clinical Trials Overview 57
Table 97: Endosleeve - Product Status 57
Table 98: Endosleeve - Product Description 57
Table 99: Second Generation Liner Device - Product Status 58
Table 100: Second Generation Liner Device - Product Description 58
Table 101: Mmtc, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
Table 102: Wearable BAT Monitor - Product Status 59
Table 103: Wearable BAT Monitor - Product Description 59
Table 104: National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 60
Table 105: Weight Management Device - Product Status 60
Table 106: Weight Management Device - Product Description 60
Table 107: Precision Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61
Table 108: Flow Control Device - Obesity - Product Status 61
Table 109: Flow Control Device - Obesity - Product Description 61
Table 110: Satiety Inc Pipeline Products & Ongoing Clinical Trials Overview 62
Table 111: TOGA System - Product Status 62
Table 112: TOGA System - Product Description 62
Table 113: Satiety Inc - Ongoing Clinical Trials Overview 63
Table 114: TOGA System - Endoscopic Bariatric Stapling Pilot Study 64
Table 115: Sensate LLC Pipeline Products & Ongoing Clinical Trials Overview 65
Table 116: Sensate Anchored Gastric Device - Product Status 65
Table 117: Sensate Anchored Gastric Device - Product Description 65
Table 118: Silhouette Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
Table 119: nObese Device - Product Status 66
Table 120: nObese Device - Product Description 66
Table 121: SLIMEDICS LTD Pipeline Products & Ongoing Clinical Trials Overview 67
Table 122: Intra Gastric Implant - Product Status 67
Table 123: Intra Gastric Implant - Product Description 67
Table 124: Spatz FGIA, Inc Pipeline Products & Ongoing Clinical Trials Overview 68
Table 125: Spatz3 Adjustable Balloon System - Product Status 68
Table 126: Spatz3 Adjustable Balloon System - Product Description 68
Table 127: Standard Bariatrics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69
Table 128: Gastrectomy Stapling Guide - Product Status 69
Table 129: Gastrectomy Stapling Guide - Product Description 69
Table 130: Surefire Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 70
Table 131: Surefire Infusion Catheter System - Obesity - Product Status 70
Table 132: Surefire Infusion Catheter System - Obesity - Product Description 70
Table 133: SynerZ Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
Table 134: Aegis Device - Product Status 71
Table 135: Aegis Device - Product Description 71
Table 136: The Sheikh Zayed Institute for Pediatric Surgical Innovation Pipeline Products & Ongoing Clinical Trials Overview 72
Table 137: Obesity Balloon - Product Status 72
Table 138: Obesity Balloon - Product Description 72
Table 139: TransEnterix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
Table 140: Intraluminal Gastroplasty Device - Obesity - Product Status 73
Table 141: Intraluminal Gastroplasty Device - Obesity - Product Description 73
Table 142: Tulip Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 74
Table 143: Tulip Capsule - Product Status 74
Table 144: Tulip Capsule - Product Description 74
Table 145: UAS LifeSciences LLC Pipeline Products & Ongoing Clinical Trials Overview 75
Table 146: Ingestible Gastrointestinal Sampling Device - Product Status 75
Table 147: Ingestible Gastrointestinal Sampling Device - Product Description 75
Table 148: University of Florida Pipeline Products & Ongoing Clinical Trials Overview 76
Table 149: Mutated Gene Repair System - Product Status 76
Table 150: Mutated Gene Repair System - Product Description 76
Table 151: University of Miami Pipeline Products & Ongoing Clinical Trials Overview 77
Table 152: EEA Anvil Placement Device - Product Status 77
Table 153: EEA Anvil Placement Device - Product Description 77
Table 154: ValenTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 78
Table 155: ValenTx Endoluminal Bypass System - Product Status 78
Table 156: ValenTx Endoluminal Bypass System - Product Description 78
Table 157: ValenTx, Inc. - Ongoing Clinical Trials Overview 79
Table 158: ValenTx Endoluminal Bypass System - An Open Label Trial of the Safety and Effectiveness of the ValenTx Endo Bypass System and Use of the Endoscopic Anchor Placement Device in Obese Subjects 80
Table 159: ValenTx Endoluminal Bypass System - Safety and Efficacy of the ValenTx EndoPass System for the Treatment of Obese Subjects: The ePass Clinical Trial 80
Table 160: Vancive Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview 81
Table 161: 7-Day Body Monitor Patch - Product Status 81
Table 162: 7-Day Body Monitor Patch - Product Description 81
Table 163: Vibrynt, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
Table 164: PREVAIL Implant System - Product Status 82
Table 165: PREVAIL Implant System - Product Description 82
Table 166: Glossary 162

1.2 List of Figures
Figure 1: Bariatric Surgery Devices - Pipeline Products by Stage of Development 12
Figure 2: Bariatric Surgery Devices - Pipeline Products by Segment 13
Figure 3: Bariatric Surgery Devices - Pipeline Products by Territory 14
Figure 4: Bariatric Surgery Devices - Pipeline Products by Regulatory Path 15
Figure 5: Bariatric Surgery Devices - Pipeline Products by Estimated Approval Date 16
Figure 6: Bariatric Surgery Devices - Ongoing Clinical Trials 17
Filed in: Medical Device
Publisher : GlobalData